Approval · Notice of Compliance 29966 · 2023
TRODELVY: Notice of Compliance 29966
Issued January 20, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29966
- Date
- January 20, 2023
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Fullfillment of Commitment 1b of the Post-Decision Letter dated September 28, 2021 issued under NDS Control number 248753
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRODELVY | Not yet assigned | — |
Medicinal ingredients
- SACITUZUMAB GOVITECAN 180 MG per VIAL